[ Price : $8.95]
FDA approves Novocures Optune Pax for use in combination with gemcitabine and nab-paclitaxel for adults with locally advanced panc...[ Price : $8.95]
FDA sends Sobi Inc. an untitled letter that cites a direct-to-consumer television advertisement for its myelofibrosis drug Vonjo (...[ Price : $8.95]
FDA warns Phoenix, AZ-based Signature Formulations about repeat CGMP violations in its manufacturing of finished drugs as a contra...[ Price : $8.95]
FDA cites Lonza Portsmouth for significant manufacturing and quality control deficiencies at its cell therapy facility where Verte...[ Price : $8.95]
A Washington Post opinion article takes issue with FDAs recent decision to reject a low-dose atropine treatment for pediatric myop...[ Price : $8.95]
FDA moves to blunt criticism of the Commissioners National Priority Voucher Program with a news release containing 18 questions an...[ Price : $8.95]
FDA warns Mark Dacey of Denver, CO, about failing to obtain informed consent for two clinical investigations he conducted.[ Price : $8.95]
FDA and industry representatives report agreement on several issues in the 1/21 MDUFA 6 negotiating session.